| scholarly article | Q13442814 |
| P50 | author | Norman Farnsworth | Q19667267 |
| Shao-Nong Chen | Q40259595 | ||
| Guido F Pauli | Q40259636 | ||
| Lucas R Chadwick | Q51810873 | ||
| Richard van Breemen | Q56102435 | ||
| Giovanni Appendino | Q56462099 | ||
| Alberto Minassi | Q58377013 | ||
| Judy L. Bolton | Q84260388 | ||
| P2093 | author name string | Jian Guo | |
| David C Lankin | |||
| Cassia R Overk | |||
| Daniel D Lantvit | |||
| P2860 | cites work | Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women | Q24678682 |
| Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense) | Q24682645 | ||
| The OECD program to validate the rat uterotrophic bioassay: an overview | Q24816099 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials | Q30870451 | ||
| Dietary isoflavones: biological effects and relevance to human health | Q33542660 | ||
| Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). | Q33828969 | ||
| Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer | Q33865219 | ||
| The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids | Q33929539 | ||
| Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement | Q34100626 | ||
| Estrogens and congeners from spent hops (Humulus lupulus). | Q34379856 | ||
| Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort | Q34552706 | ||
| In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus L.). | Q35574541 | ||
| Phytoestrogens in botanical dietary supplements: implications for cancer | Q35702422 | ||
| Chemical and biological characterization and clinical evaluation of botanical dietary supplements: a phase I red clover extract as a model. | Q35794211 | ||
| Quantitative 1H NMR: development and potential of a method for natural products analysis. | Q36023495 | ||
| A routine experimental protocol for qHNMR illustrated with Taxol. | Q36085166 | ||
| A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. | Q39358497 | ||
| Clinical review 92: Phytoestrogens | Q41064984 | ||
| Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms | Q43614524 | ||
| Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin | Q43897631 | ||
| Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses | Q44148641 | ||
| Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones | Q44483249 | ||
| Two major metabolites of 8-prenylnaringenin are estrogenic in vitro | Q45151435 | ||
| Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes | Q45265965 | ||
| Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices | Q46434153 | ||
| Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results | Q46484277 | ||
| Extraction and quantification of daidzein and genistein in food | Q46674342 | ||
| Effects of selective estrogen receptor agonists on food intake and body weight gain in rats | Q46718511 | ||
| Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment | Q46979707 | ||
| Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women | Q49043125 | ||
| Oestrous and dioestrous components of the ovarian inhibition on hunger in the rat | Q52319998 | ||
| Antigonadotropic activity of hop extract | Q67507191 | ||
| Extraction of the hormonal substance from hop | Q71341478 | ||
| [Estrogens in hops and beer; preliminary report] | Q73267068 | ||
| Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats | Q77439000 | ||
| Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones | Q77664958 | ||
| What are bioidentical hormones? Natural. Bioidentical. Compounded. Confusion about these terms is only adding to the confusion over hormone therapy | Q79373069 | ||
| Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats | Q79894524 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Humulus lupulus | Q104212 |
| Trifolium pratense | Q156635 | ||
| P304 | page(s) | 30-9 | |
| P577 | publication date | 2008-10-22 | |
| P1433 | published in | Chemico-biological Interactions | Q14923137 |
| P1476 | title | In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin | |
| P478 | volume | 176 |
| Q54945672 | A Hop Extract Lifenol® Improves Postmenopausal Overweight, Osteoporosis, and Hot Flash in Ovariectomized Rats. |
| Q47642476 | A standardized Humulus lupulus (L.) ethanol extract partially prevents ovariectomy-induced bone loss in the rat without induction of adverse effects in the uterus |
| Q37199636 | Analytical methods for quantitation of prenylated flavonoids from hops. |
| Q24628250 | Antiproliferative activity and synthesis of 8-prenylnaringenin derivatives by demethylation of 7-O- and 4′-O-substituted isoxanthohumols |
| Q38117195 | Beer and beer compounds: physiological effects on skin health |
| Q34557379 | Biological and chemical standardization of a hop (Humulus lupulus) botanical dietary supplement |
| Q34224297 | Biological characterization of non-steroidal progestins from botanicals used for women's health. |
| Q24607818 | Botanical modulation of menopausal symptoms: mechanisms of action? |
| Q28065998 | Botanicals and Their Bioactive Phytochemicals for Women's Health |
| Q48231458 | DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health. |
| Q37396313 | Differential regulation of detoxification enzymes in hepatic and mammary tissue by hops (Humulus lupulus) in vitro and in vivo |
| Q24631085 | Disposition of hop prenylflavonoids in human breast tissue |
| Q48196741 | Effect of aqueous extract of Solanum xanthocarpum Schrad. & Wendl. on postmenopausal syndrome in ovariectomized rats |
| Q55100288 | Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication. |
| Q37007979 | Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms |
| Q53732495 | Evaluation of estrogenic potency of a standardized hops extract on mammary gland biology and on MNU-induced mammary tumor growth in rats. |
| Q35013915 | Evaluation of the estrogenic effects of dietary perinatal Trifolium pratense. |
| Q35656216 | Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A). |
| Q52690952 | Human-relevant potency threshold (HRPT) for ERα agonism. |
| Q34516562 | Identifying botanical mechanisms of action |
| Q37704691 | Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols |
| Q28260010 | Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats |
| Q37283111 | Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health. |
| Q34695475 | Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. |
| Q47157326 | Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones |
| Q35181767 | Simultaneous determination and pharmacokinetic study of three isoflavones from Trifolium pratense extract in rat plasma by LC-MS/MS. |
| Q88718603 | Soybean-Hop Alleviates Estrogen Deficiency-Related Bone Loss and Metabolic Dysfunction in Ovariectomized Rats Fed a High-Fat Diet |
| Q57072895 | The Hop Polyphenols Xanthohumol and 8-Prenyl-Naringenin Antagonize the Estrogenic Effects of Mycotoxins in Human Endometrial Cancer Cells |
Search more.